Biotech

All Articles

Navigator increases $100M to build new autoimmune pipe

.Navigator Medicines has equipped on its own along with $one hundred thousand in series A funds as t...

Duality finds cash for ADC tests as IPO wave infects Asia

.China's Duality Biotherapeutics has actually filed (PDF) paperwork for a Hong Kong IPO, looking for...

YolTech sells China civil liberties to gene editing therapy for $29M

.4 months after Chinese genetics editing and enhancing company YolTech Rehabs took its own cholester...

Addex sell increases after Indivior provides to $300M for compound

.Indivior is picking up a tiny particle allosteric modulator designed to deal with compound usage pr...

Molecular Partners tweaks AML test over 'suboptimal direct exposure'

.Molecular Partners has actually determined "suboptimal exposure" to its tetra-specific T-cell engag...

Despite blended market, a venture capital rebirth can be coming in Europe: PitchBook

.While the biotech financial investment scene in Europe has slowed rather complying with a COVID-19 ...

8 months after a $213M fundraise, gene editor Volume creates cuts

.After raising $213 million in 2023-- among the year's most extensive private biotech rounds-- Tome ...

BioMarin builds director team with biotech vets-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our roundup of significant management hirings, shootings an...

Biopharma Q2 VC attacked highest degree considering that '22, while M&ampA decreased

.Equity capital financing right into biopharma cheered $9.2 billion around 215 sell the 2nd quarter ...

Bicara, Zenas find IPOs to drive late-phase assets towards market

.Bicara Therapeutics and Zenas Biopharma have actually delivered fresh inspiration to the IPO market...